CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 91 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 3.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,929,000 | +65.6% | 884,969 | +4.0% | 1.29% | +47.5% |
| Q2 2022 | $3,581,000 | +296.6% | 850,647 | +2337.0% | 0.87% | +439.5% |
| Q4 2017 | $903,000 | -45.1% | 34,905 | -71.0% | 0.16% | -37.0% |
| Q1 2016 | $1,645,000 | -35.0% | 120,423 | -9.7% | 0.26% | -22.4% |
| Q4 2015 | $2,529,000 | +0.5% | 133,317 | -0.6% | 0.33% | -17.0% |
| Q3 2015 | $2,517,000 | +105.3% | 134,121 | +62.9% | 0.40% | +179.0% |
| Q2 2015 | $1,226,000 | -1.8% | 82,319 | -0.1% | 0.14% | -0.7% |
| Q1 2015 | $1,248,000 | -67.4% | 82,434 | -72.8% | 0.14% | -81.5% |
| Q3 2014 | $3,823,000 | – | 303,142 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |